Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03813121 · ClinicalTrials.gov registry record · Phase 1
The Effects of Sedatives on Tobacco Use Disorder
A Phase 1 study, sponsored by Wake Forest University Health Sciences.
- Completed
- Registry status
- Phase 1
- Development phase
- 10
- Enrollment target
NCT03813121 is a Phase 1 study that has completed, run by Wake Forest University Health Sciences. The registered enrollment target is 10 participants.
The verdict
NCT03813121, a Phase 1 study, has completed, sponsored by Wake Forest University Health Sciences.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 10 participants
- Enrollment target
Study Summary
This proposal will obtain preliminary data on the effect of a single sub-anesthetic dose of a sedative on cigarette craving and smoking behavior as well as measuring tolerability and acceptability.
Interventions
- DRUG midazolam intravenous infusion
- DRUG placebo intravenous infusion
- DRUG ketamine intravenous infusion
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2019-06-01 |
| Est. Completion | 2021-08-31 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03813121
The ClinicalTrials.gov registry entry for NCT03813121 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Wake Forest University Health Sciences, which has 1,140 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which midazolam intravenous infusion is the first listed.
NCT03813121 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03813121 about?
NCT03813121 is a clinical study titled "The Effects of Sedatives on Tobacco Use Disorder". This proposal will obtain preliminary data on the effect of a single sub-anesthetic dose of a sedative on cigarette craving and smoking behavior as well as measuring tolerability and acceptability.
What is the current status of trial NCT03813121?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 10 participants. The study started on 2019-06-01. Estimated completion is 2021-08-31.
What interventions are being tested in trial NCT03813121?
The interventions under investigation include: midazolam intravenous infusion (DRUG), placebo intravenous infusion (DRUG), ketamine intravenous infusion (DRUG).
Who is sponsoring clinical trial NCT03813121?
This trial is sponsored by Wake Forest University Health Sciences, which has 1,140 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.